|
Oct. 23 Thursday
|
|
09:00~09:30
|
Breast Cancer Management- Past, Present and Future
|
Umberto Veronesi (It)
|
|
Epidemiology
|
|
|
09:30~10:00
|
Breast Cancer: A Global Epidemic
|
Tongzhang Zheng(Fr)
|
|
10:00~10:30
|
Status of breast cancer in China
|
Zhimin Shao (CN)
|
|
Basic Research
|
|
|
15:00~15:25
|
Proteomics approach to discover biomarkers in breast cancer
|
Dong Young Noh (Kr)
|
|
15:25~15:50
|
Stem cells and breast cancer
|
Maria Grazia Daidone (It)
|
|
Breast Imaging
|
|
|
16:15~16:40
|
MRI Imaging of the Breast
|
Steve Harms (USA)
|
|
16:40~17:05
|
Breast Ultrasound and Elastography
|
Dominique Amy (Fr)
|
|
17:05~17:30
|
Ultrasound screening for breast cancer
|
Chiun Sheng Huang (TW)
|
|
Oct. 24 Friday
|
|
Neoadjuvant Therapy
|
|
|
09:00~09:40
|
Neoadjuvant trials in Asia
|
Louis Chow (HK)
|
|
09:40~10:10
|
Neoadjuvant treatment of breast cancer in Japan
|
Shinji Ohno (Jp)
|
|
Breast Surgery
|
|
|
14:00~14:25
|
Sentinel lymph node biopsy in China
|
Yongsheng Wang (CN)
|
|
14:25~14:50
|
Resolving controversies in sentinel lymph node biopsy
|
Paolo Veronesi (It)
|
|
14:50~15:15
|
Fiberoptic ductoscopy combined with cytology testing in the patients of spontaneous nipple discharge.
|
Kunwei Shen (CN)
|
|
15:15~15:40
|
Oncoplastic Surgery
|
Jean Yves Petit (It)
|
|
Breast Pathology
|
|
|
16:00~16:30
|
Implications of Recent Sub-typing of Infiltrating Carcinoma
|
Hironoubu Sasano (Jp)
|
|
16:30~17:00
|
Biologic characteristics of breast cancer
|
Giuseppe Viale (It)
|
|
Oct. 25 Saturday
|
|
Radiation Therapy
|
|
|
09:00~09:30
|
The Role of Intraoperative Irradiation in the Management of Early Stage Breast Cancer
|
Roberto Orecchia (It)
|
|
09:30~10:00
|
Radiotherapy in the management of node positive breast cancer
|
Zhihao Yu (CN)
|
|
10:00~10:30
|
Possible role of proton therapy in breast cancer
|
Kyung Hwan Shin (Kr)
|
|
Adjuvant Systemic Therapy for Early Breast Cancer
|
|
|
14:00~14:30
|
Management of Endocrine Responsive Patients
|
Per Lonning (Nw)
|
|
14:30~15:00
|
Management of Endocrine Non-responsive Patients
|
ZF Jiang (CN)
|
|
15:00~15:30
|
The incorporation of thyrosine kinase inhibition into the systemic therapy
|
Stefan Gluck (US)
|
|
Complimentary Medicine and Rehabilitation
|
|
|
15:50~16:20
|
Use of bisphosphonates in adjuvant and advanced breast cancer
|
Matti Aapro(Sw)
|
|
16:20~16:50
|
Principles of cancer management in Chinese Medicine
|
Luming Liu (CN)
|
|
16:50~17:20
|
Quality of life is both a goal of treatment and predictor of outcome in breast cancer
|
Alan Coates (AU)
|
|
Oct. 26 Sunday
|
|
Metastatic Breast Cancer
|
|
|
09:00~09:20
|
Optimal chemotherapy in China
|
Binghe Xu (CN)
|
|
09:20~09:40
|
Management of hormonal responsive metastatic breast cancer
|
Xichun Hu (CN)
|
|
Novel Therapy and Clinical Trials
|
|
|
10:30~11:00
|
Individually tailored treatment: The potential role of gene array profiles
|
Masakazu Toi (Jp)
|
|
11:00~11:30
|
Tailoring clinical trials for the best care of the patients
|
Aron Goldhirsch (Sw)
|
